KQED’s ‘Health Dialogues’ Program to Examine ‘Lifestyle Drugs’
KQED's "Health Dialogues," a live monthly call-in program sponsored by the California Endowment to examine health care issues in the state, tonight will address the shift in pharmaceutical industry research from "life-saving therapies" to "more lucrative lifestyle drugs," such as Viagra and allergy medications. Tonight's "Health Dialogues" also will discuss the increased cost of prescription drugs and the impact of direct-to-consumer advertising campaigns sponsored by pharmaceutical companies. Guests on tonight's program include Dr. David Gollaher, president and CEO of the California Healthcare Institute -- a not-for-profit public policy research organization that represents pharmaceutical and biotechnology companies in the state -- and Dr. Sharon Levine, associate executive director of the Kaiser Permanente medical group. The program will air at 7 p.m. PT. Check local radio listings for availability. The program will be available online in RealPlayer Audio within one day of the broadcast (KQED, "Health Dialogues" release, 6/10).This is part of the California Healthline Daily Edition, a summary of health policy coverage from major news organizations. Sign up for an email subscription.